Established in 2020, Celix Pharma is committed to bringing high quality, affordable, generic medicines into the UK for the health and well-being of patients, in line with its stated purpose “...for better health”. By bridging gaps in the market across dosage forms, therapeutic areas and market channels, Celix intends to deliver substantial value to patients, payers, healthcare providers and its partners. Celix Pharma’s business model is built around creating a commercially led, customer focused organization supported with strategic partnerships in R&D and manufacturing.
Celix Pharma is headquartered in the UK and is founded by professionals with considerable experience in the European pharmaceutical space across the entire value chain of a generic product, from research & development to commercialization.
Celix Pharma operates within both primary and secondary care sectors and aims to provide its customers with a range of generics, branded generics and hospital specialty products.
Celix Pharma’s strengths lie in its deep understanding of the market and its customer relationships across the retail and hospital channels. Using its market knowledge and network, Celix Pharma aims to seamlessly connect the dots across various technical functions such as R&D, manufacturing, regulatory, quality, intellectual property to ensure smooth execution in bringing products from idea to launch.